Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide

Endocrinology

Volumn 149, Issue 9, 2008, Pages 4486-4498

  Moss, Nicholas G ^a   Fellner, Robert C ^a   Qian, Xun ^b   Yu, Sharon J ^a   Li, Zhiping ^c   Nakazato, Masamitsu ^d   Goy, Michael F ^a,e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN PRECURSOR; PROUROGUANYLIN; RECOMBINANT PROTEIN; RECOMBINANT PROUROGUANYLIN; UNCLASSIFIED DRUG; UROGUANYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IMMUNOASSAY; INTESTINE SECRETION; KIDNEY FUNCTION; MALE; MEDIATOR; NATRIURESIS; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; SODIUM EXCRETION; URINARY EXCRETION;

ANIMALS; GASTROINTESTINAL HORMONES; INTESTINES; KIDNEY; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDES; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SODIUM; TISSUE EXTRACTS;

EID: 50449088585     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1725     Document Type: Article

References (70)

1. Lennane RJ, Carey RM, Goodwin TJ, Peart WS 1975 A comparison of natriuresis after oral and intravenous sodium loading in sodium-depleted man: evidence for a gastrointestinal or portal monitor of sodium intake. Clin Sci Mol Med 49:437-440
2. Carey RM, Smith JR, Ortt EM 1976 Gastrointestinal control of sodium excretion in sodium-depleted conscious rabbits. Am J Physiol 230:1504-1508
3. Carey RM 1978 Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone. Circ Res 43:19-23
4. Singer DR, Markandu ND, Buckley MG, Miller MA, Sagnella GA, MacGregor GA 1998 Contrasting endocrine responses to acute oral compared with intravenous sodium loading in normal humans. Am J Physiol 274(1 Pt 2):F111-F119
5. Forte Jr LR 2004 Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics. Pharmacol Ther 104:137-162
6. Forte LR 2003 A novel role for uroguanylin in the regulation of sodium balance. J Clin Invest 112:1138-1141
7. Lorenz JN, Nieman M, Sabo J, Sanford LP, Hawkins JA, Elitsur N, Gawenis LR, Clarke LL, Cohen MB 2003 Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J Clin Invest 112:1244-1254
8. Elitsur N, Lorenz JN, Hawkins JA, Rudolph JA, Witte D, Yang LE, McDonough AA, Cohen MB 2006 The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response. J Pediatr Gastroenterol Nutr 43(Suppl 1):S74-S81
9. Hess R, Kuhn M, Schulz-Knappe P, Raida M, Fuchs M, Klodt J, Adermann K, Kaever V, Cetin Y, Forssmann WG 1995 GCAP-II: isolation and characterization of the circulating form of human uroguanylin. FEBS Lett 374:34-38
10. Fan X, Hamra FK, Freeman RH, Eber SL, Krause WJ, Lim RW, Pace VM, Currie MG, Forte LR 1996 Uroguanylin: cloning of preprouroguanylin cDNA, mRNA expression in the intestine and heart and isolation of uroguanylin and prouroguanylin from plasma. Biochem Biophys Res Commun 219:457-462
11. Kinoshita H, Fujimoto S, Nakazato M, Yokota N, Date Y, Yamaguchi H, Hisanaga S, Eto T 1997 Urine and plasma levels of uroguanylin and its molecular forms in renal diseases. Kidney Int 52:1028-1034
12. Forte LR, Fan X, Hamra FK 1996 Salt and water homeostasis: uroguanylin is a circulating peptide hormone with natriuretic activity. Am J Kidney Dis 28:296-304
13. Carrithers SL, Hill MJ, Johnson BR, O'Hara SM, Jackson BA, Ott CE, Lorenz J, Mann EA, Giannella RA, Forte LR, Greenberg RN 1999 Renal effects of uroguanylin and guanylin in vivo. Braz J Med Biol Res 32:1337-1344
14. Fonteles MC, Greenberg RN, Monteiro HS, Currie MG, Forte LR 1998 Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am J Physiol 275(2 Pt 2):F191-F197
15. Perkins A, Goy MF, Li Z 1997 Uroguanylin is expressed by enterochromaffin cells in the rat gastrointestinal tract. Gastroenterology 113:1007-1014
16. Nakazato M, Yamaguchi H, Date Y, Miyazato M, Kangawa K, Goy MF, Chino N, Matsukura S 1998 Tissue distribution, cellular source, and structural analysis of rat immunoreactive uroguanylin. Endocrinology 139:5247-5254
17. Cui L, Blanchard RK, Coy LM, Cousins RJ 2000 Prouroguanylin overproduction and localization in the intestine of zinc-deficient rats. J Nutr 130:2726-2732
18. Forsberg EJ, Miller RJ 1983 Regulation of serotonin release from rabbit intestinal enterochromaffin cells. J Pharmacol Exp Ther 227:755-766
19. Nilsson O, Ahlman H, Geffard M, Dahlstrom A, Ericson LE 1987 Bipolarity of duodenal enterochromaffin cells in the rat. Cell Tissue Res 248:49-54
20. Carrithers SL, Jackson BA, Cai WY, Greenberg RN, Ott CE 2002 Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestine. Regul Pept 107:87-95
21. Steinbrecher KA, Rudolph JA, Luo G, Cohen MB 2002 Coordinate upregulation of guanylin and uroguanylin expression by hypertonicity in HT29-18-N2 cells. Am J Physiol Cell Physiol 283:C1729-C1737
22. Miyazato M, Nakazato M, Matsukura S, Kangawa K, Matsuo H 1996 Uroguanylin gene expression in the alimentary tract and extra-gastrointestinal tissues. FEBS Lett 398:170-174
23. Li Z, Perkins AG, Peters MF, Campa MJ, Goy MF 1997 Purification, cDNA sequence, and tissue distribution of rat uroguanylin. Regul Pept 68:45-56
24. Hill O, Cetin Y, Cieslak A, Magert HJ, Forssmann WG 1995 A new human guanylate cyclase-activating peptide (GCAP-II, uroguanylin): precursor cDNA and colonic expression. Biochim Biophys Acta 1253:146-149
25. Fan X, Wang Y, London RM, Eber SL, Krause WJ, Freeman RH, Forte LR 1997 Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems. Endocrinology 138:4636-4648
26. Magert HJ, Reinecke M, David I, Raab HR, Adermann K, Zucht HD, Hill O, Hess R, Forssmann WG 1998 Uroguanylin: gene structure, expression, processing as a peptide hormone, and co-storage with somatostatin in gastrointestinal D-cells. Regul Pept 73:165-176
27. Kulaksiz H, Cetin Y 2001 Uroguanylin and guanylate cyclase C in the human pancreas: expression and mutuality of ligand/receptor localization as indicators of intercellular paracrine signaling pathways. J Endocrinol 170:267-275
28. Kulaksiz H, Rausch U, Vaccaro R, Renda TG, Cetin Y 2001 Guanylin and uroguanylin in the parotid and submandibular glands: potential intrinsic regulators of electrolyte secretion in salivary glands. Histochem Cell Biol 115:527-533
29. Kulaksiz H, Cetin Y 2002 The electrolyte/fluid secretion stimulatory peptides guanylin and uroguanylin and their common functional coupling proteins in the rat pancreas: a correlative study of expression and cell-specific localization. Pancreas 25:170-175
30. Jaleel M, London RM, Eber SL, Forte LR, Visweswariah SS 2002 Expression of the receptor guanylyl cyclase C and its ligands in reproductive tissues of the rat: a potential role for a novel signaling pathway in the epididymis. Biol Reprod 67:1975-1980
31. Maake C, Auf der Maur F, Jovanovic K, Reinecke M, Hauri D, John H 2003 Occurrence and localization of uroguanylin in the aging human prostate. Histochem Cell Biol 119:69-76
32. Lee SH, Paeng JP, Jung HH, Lee SH, Lee HM, Kwon SY, Lim KJ, Jung KY 2004 Expression of guanylin and uroguanylin mRNA in human nasal mucosa and nasal polyps. Acta Otolaryngol 124:179-185
33. Qian X, Prabhakar S, Nandi A, Visweswariah SS, Goy MF 2000 Expression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine. Endocrinology 141:3210-3224
34. Nakazato M, Yamaguchi H, Kinoshita H, Kangawa K, Matsuo H, Chino N, Matsukura S 1996 Identification of biologically active and inactive human uroguanylins in plasma and urine and their increases in renal insufficiency. Biochem Biophys Res Commun 220:586-593
35. Fukae H, Kinoshita H, Fujimoto S, Kita T, Nakazato M, Eto T 2002 Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats. Nephron 92:373-378
36. Kikuchi M, Fujimoto S, Fukae H, Kinoshita H, Kita T, Nakazato M, Eto T 2005 Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome. J Am Soc Nephrol 16:392-397
37. Greenberg RN, Hill M, Crytzer J, Krause WJ, Eber SL, Hamra FK, Forte LR 1997 Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. J Investig Med 45:276-282
38. Carrithers SL, Ott CE, Hill MJ, Johnson BR, Cai W, Chang JJ, Shah RG, Sun C, Mann EA, Fonteles MC, Forte LR, Jackson BA, Giannella RA, Greenberg RN 2004 Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor. Kidney Int 65:40-53
39. Miyazato M, Nakazato M, Yamaguchi H, Date Y, Kojima M, Kangawa K, Matsuo H, Matsukura S 1996 Cloning and characterization of a cDNA encoding a precursor for human uroguanylin. Biochem Biophys Res Commun 219:644-648
40. Bendtsen JD, Nielsen H, von Heijne G, Brunak S 2004 Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340:783-795
41. Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, Smith CE 1992 Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci USA 89:947-951
42. Schulz S, Chrisman TD, Garbers DL 1992 Cloning and expression of guanylin. Its existence in various mammalian tissues. J Biol Chem 267:16019-16021
43. Hamra FK, Fan X, Krause WJ, Freeman RH, Chin DT, Smith CE, Currie MG, Forte LR 1996 Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases. Endocrinology 137:257-265
44. Fan X, Hamra FK, London RM, Eber SL, Krause WJ, Freeman RH, Smith CE, Currie MG, Forte LR 1997 Structure and activity of uroguanylin and guanylin from the intestine and urine of rats. Am J Physiol 273(5 Pt 1):E957-E964
45. Hamra FK, Eber SL, Chin DT, Currie MG, Forte LR 1997 Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity. Proc Natl Acad Sci USA 94:2705-2710
46. Blanchard RK, Cousins RJ 1997 Upregulation of rat intestinal uroguanylin mRNA by dietary zinc restriction. Am J Physiol 272(5 Pt 1):G972-G978
47. Whitaker TL, Witte DP, Scott MC, Cohen MB 1997 Uroguanylin and guanylin: distinct but overlapping patterns of messenger RNA expression in mouse intestine. Gastroenterology 113:1000-1006
48. London RM, Krause WJ, Fan X, Eber SL, Forte LR 1997 Signal transduction pathways via guanylin and uroguanylin in stomach and intestine. Am J Physiol 273(1 Pt 1):G93-G105
49. Pass G, Freeth G 1993 The rat. ANZCCART News 6:1-4
50. Kinoshita H, Nakazato M, Yamaguchi H, Matsukura S, Fujimoto S, Eto T 1997 Increased plasma guanylin levels in patients with impaired renal function. Clin Nephrol 47:28-32
51. Scheving LA, Jin WH 1999 Circadian regulation of uroguanylin and guanylin in the rat intestine. Am J Physiol 277(6 Pt 1):C1177-C1183
52. Forte LR, Eber SL, Fan X, London RM, Wang Y, Rowland LM, Chin DT, Freeman RH, Krause WJ 1999 Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family. Endocrinology 140:1800-1806
53. Santos-Neto MS, Carvalho AF, Monteiro HS, Forte LR, Fonteles MC 2006 Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney. Regul Pept 136:14-22
54. Qian X, Moss NG, Fellner RC, Goy MF 2008 Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules. Endocrinology 149:4510-4518
55. Duckert P, Brunak S, Blom N 2004 Prediction of proprotein convertase cleavage sites. Protein Eng Des Sel 17:107-112
56. Fukae H, Kinoshita H, Fujimoto S, Nakazato M, Eto T 2000 Plasma concentration of uroguanylin in patients on maintenance dialysis therapy. Nephron 84:206-210
57. Kinoshita H, Fujimoto S, Fukae H, Yokota N, Hisanaga S, Nakazato M, Eto T 1999 Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron 81:160-164
58. Rehfeld JF 1998 The new biology of gastrointestinal hormones. Physiol Rev 78:1087-1108
59. Varro A, Yegen B, Dockray GJ 1993 Control of tissue progastrin concentrations in the rat. Exp Physiol 78:327-336
60. Liddle RA, Goldfine ID, Williams JA 1984 Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87:542-549
61. Clerico A, Del Ry S, Giannessi D 2000 Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 46:1529-1534
62. Clauser E, Bouhnik J, Gonzalez MF, Corvol P, Menard J 1984 Influence of converting-enzyme inhibition on rat des-angiotensin I-angiotensinogen. Am J Physiol 246(2 Pt 1):E129-E133
63. Bouhnik J, Savoie F, Baussant T, Michaud A, Alhenc-Gelas F, Corvol P 1988 Effect of thyroidectomy on rat T-kininogen. Am J Physiol 255(4 Pt 1):E411-E415
64. Hidaka Y, Ohno M, Hemmasi B, Hill O, Forssmann WG, Shimonishi Y 1998 In vitro disulfide-coupled folding of guanylyl cyclase-activating peptide and its precursor protein. Biochemistry 37:8498-8507
65. Hidaka Y, Shimono C, Ohno M, Okumura N, Adermann K, Forssmann WG, Shimonishi Y 2000 Dual function of the propeptide of prouroguanylin in the folding of the mature peptide: disulfide-coupled folding and dimerization. J Biol Chem 275:25155-25162
66. Laney Jr DW, Bezerra JA, Kosiba JL, Degen SJ, Cohen MB 1994 Upregulation of Escherichia coli heat-stable enterotoxin receptor in regenerating rat liver. Am J Physiol 266(5 Pt 1):G899-G906
67. Bulbring E, Lin RC 1958 The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity. J Physiol 140:381-407
68. Burks TF, Long JP 1966 5-Hydroxytryptamine release into dog intestinal vasculature. Am J Physiol 211:619-625
69. Gamse R, Mroz E, Leeman S, Lembeck F 1978 The intestine as source of immunoreactive substance P in plasma of the cat. Naunyn Schmiedebergs Arch Pharmacol 305:17-21
70. Ahlman H, DeMagistris L, Zinner M, Jaffe BM 1981 Release of immunoreactive serotonin into the lumen of the feline gut in response to vagal nerve stimulation. Science 213:1254-1255